Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Petra S A Becker"'
Autor:
Claudia Brehm, Sabine Huenecke, Andrea Quaiser, Ruth Esser, Melanie Bremm, Stephan Kloess, Jan Soerensen, Hermann Kreyenberg, Christian Seidl, Petra S A Becker, Heiko Mühl, Thomas Klingebiel, Peter Bader, Jakob R Passweg, Dirk Schwabe, Ulrike Koehl
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27351 (2011)
In an ongoing clinical phase I/II study, 16 pediatric patients suffering from high risk leukemia/tumors received highly purified donor natural killer (NK) cell immunotherapy (NK-DLI) at day (+3) +40 and +100 post haploidentical stem cell transplantat
Externí odkaz:
https://doaj.org/article/ce83b83fe8c94d1faca141a36b73b48a
Autor:
Peter Reinhardt, Christian Seidl, Hubert Schrezenmeier, Heike Bialleck, Erhard Seifried, Arnd Schwebig, Sreekanth Gattu, Susanne Brauninger, Petra S. A. Becker, Beate Luxembourg, Halvard Bonig, Chrysanthi Tsamadou, Natalia Kaliakina, Pritibha Singh, Miriam Schulz, Joannis Mytilineos, M Wiesneth
Publikováno v:
Transfusion. 56:3055-3064
BACKGROUND Biosimilar granulocyte-colony-stimulating factors (G-CSFs) have been available in the European Union since 2008, and Sandoz' biosimilar filgrastim was approved in the United States in March 2015 for all of the reference product's indicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a043be3ffa6a24b87fb1f6327e5491d2
https://doi.org/10.1111/trf.13853
https://doi.org/10.1111/trf.13853
Autor:
Christian Seidl, Garnet Suck, Evelyn Ullrich, Peter Bader, Torsten Tonn, Erhard Seifried, Paulina Nowakowska, Petra S. A. Becker
Publikováno v:
Cancer Immunology, Immunotherapy
Natural killer (NK) cells have been used in several clinical trials as adaptive immunotherapy. The low numbers of these cells in peripheral blood mononuclear cells (PBMC) have resulted in various approaches to preferentially expand primary NK cells f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d573a9d0ff40a10abeff786d60f762
http://europepmc.org/articles/PMC4826432
http://europepmc.org/articles/PMC4826432
Publikováno v:
Transfusion. 55:430-439
Biosimilars are approved biologics with comparable quality, safety, and efficacy to a reference product. Unlike generics, which are chemically manufactured copies of small-molecule drugs with relatively simple chemical structures, the biosimilar desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55e2c3d9326e09155250fe3093acf10c
https://doi.org/10.1111/trf.12770
https://doi.org/10.1111/trf.12770
Publikováno v:
Tissue Antigens. 86:453-455
HLA-B*50:20 contains seven nucleotide substitutions leading to four amino acid changes in the alpha-2 domain.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09b4cb9dafd591bb0c74147ad5f843b8
https://doi.org/10.1111/tan.12697
https://doi.org/10.1111/tan.12697
Autor:
Martin-Leo Hansmann, Hinrich Abken, Arne Billmeier, Sylvia Hartmann, Sebastian Newrzela, Ralf Küppers, Kathrin Warner, Sima Kameh-Var, Christian Seidl, Frederike Schmid, Benjamin Rengstl, Petra S. A. Becker, Eva Werling, Christian Weiser, Claudia Döring, Robin Wistinghausen, Tim Heinrich
Hodgkin lymphoma (HL) presents with a unique histologic pattern. Pathognomonic Hodgkin and Reed-Sternberg (HRS) cells usually account for less than 1% of the tumor and are embedded in a reactive infiltrate mainly comprised of CD4(+) T cells. HRS cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::861e6b9b00febbb9c85f6c04b2924203
https://www.ncbi.nlm.nih.gov/pubmed/27471632
https://www.ncbi.nlm.nih.gov/pubmed/27471632
Autor:
Melanie Bremm, Ruth Esser, Heiko Mühl, Petra S. A. Becker, Stephan Kloess, Peter Bader, Dirk Schwabe, Jan Soerensen, Hermann Kreyenberg, Christian Seidl, Ulrike Koehl, Andrea Quaiser, Sabine Huenecke, Claudia Brehm, Thomas Klingebiel, Jakob Passweg
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 11, p e27351 (2011)
PLoS ONE, Vol 6, Iss 11, p e27351 (2011)
In an ongoing clinical phase I/II study, 16 pediatric patients suffering from high risk leukemia/tumors received highly purified donor natural killer (NK) cell immunotherapy (NK-DLI) at day (+3) +40 and +100 post haploidentical stem cell transplantat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4d11f95e67f8cac243ab5b949762354
http://publikationen.ub.uni-frankfurt.de/files/23730/journal.pone.0027351.pdf
http://publikationen.ub.uni-frankfurt.de/files/23730/journal.pone.0027351.pdf
Autor:
Andre Willasch, Eva Rettinger, Martina Anzaghe, Ulrike Koehl, Peter Bader, Gesine Bug, Ivonne Naumann, Simone Fulda, Petra S. A. Becker, Hermann Kreyenberg, Selim Kuçi, Martin Ruthardt, Thomas Klingebiel
Publikováno v:
Cytotherapy. 14(1)
Background aims Cytokine-induced killer (CIK) cells may serve as an alternative approach to adoptive donor lymphocyte infusions (DLI) for patients with acute leukemia relapsing after haplo-identical hematopoietic stem cell transplantation (HSCT). We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292a28f42e99fa8fc81a249d1df49f1e
https://pubmed.ncbi.nlm.nih.gov/21973023
https://pubmed.ncbi.nlm.nih.gov/21973023
Publikováno v:
Tissue antigens. 78(4)
The novel HLA-C allele HLA-C*07:147 contains one nucleotide substitution in exon 2 leading to an amino acid change in the alpha 1 domain from phenylalanine to leucine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea690512f03418e2662955b5b91ef87c
https://pubmed.ncbi.nlm.nih.gov/21707538
https://pubmed.ncbi.nlm.nih.gov/21707538
Publikováno v:
Tissue antigens. 77(6)
The novel HLA-B*27:67 contains three nucleotide substitutions in exon 2 leading to two amino acid changes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4cd606d1a4b272e99198129f1329d12
https://pubmed.ncbi.nlm.nih.gov/21443637
https://pubmed.ncbi.nlm.nih.gov/21443637